RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Metabolon, Inc., the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled “Systems, ...
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy In prostate cancer, end points that reliably portend prognosis and treatment benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback